Global Biopharmaceuticals Market Size & Trends Report Segmented by Product (mAbs, Recombinant Proteins, Vaccines, Gene & Cell Therapies), Type (Innovative, Biosimilars), Therapy Area (Oncology, Autoimmune Diseases, Infectious Diseases, Rare Diseases) Forecast to 2030
The global biopharmaceuticals market is set to witness a growth rate of 12% in the next 5 years. Rising prevalence of chronic diseases; advancements in biotechnology; growing geriatric population; expansion of biosimilars; and rising R&D investments are some of the key factors driving the biopharmaceuticals market. To learn more about the research report, download a sample report.
Report Overview
Biopharmaceuticals are therapeutic products derived from biological sources, such as living cells or organisms, using advanced biotechnological processes. Unlike traditional chemical-based drugs, biopharmaceuticals are typically large, complex molecules, including proteins, nucleic acids, or living cells. Common examples include monoclonal antibodies, recombinant proteins, vaccines, and gene or cell therapies. These medicines are designed to target specific biological pathways, offering precision in treating diseases like cancer, autoimmune disorders, and genetic conditions. Biopharmaceuticals represent a cutting-edge approach to healthcare, providing innovative treatment options with improved efficacy and reduced side effects, often addressing previously unmet medical needs across a wide range of therapeutic areas. The biopharmaceutical industry remains optimistic about 2025 but less so than six months ago due to concerns over the US BIOSECURE Act, biotech funding recovery, and political changes. Geopolitical tensions and ongoing conflicts further add to industry uncertainty.
To learn more about the research report, download a sample report.
Rising prevalence of chronic diseases to propel market demand
The rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions, is a major driver of the biopharmaceuticals market. These diseases often require innovative and targeted treatments that biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, can effectively address. Unlike traditional therapies, biopharmaceuticals provide improved specificity, efficacy, and reduced side effects. Additionally, the growing global burden of chronic conditions, fueled by aging populations and lifestyle factors, underscores the need for advanced therapeutic solutions. This demand incentivizes biopharmaceutical innovation, leading to increased research, development, and adoption, thereby fueling market growth.
To learn more about the research report, download a sample report.
Key trends and emerging technologies in the biopharmaceutical industry
Key trends shaping the biopharmaceutical industry include immuno-oncology (IO) drug development, anti-obesity medications, cell and gene therapies (CGTs), personalized medicine, real-world evidence (RWE), and rising clinical trial costs. IO drug development is the leading trend, with CGTs and precision medicine continuing to transform healthcare. AI, big data, and data integration are the most disruptive technologies, optimizing processes from drug discovery to patient outcomes. AI's ability to analyze vast datasets enhances efficiency, reduces R&D costs, and improves precision medicine. As AI advances, its integration with big data will further drive innovation in value-based healthcare.
Competitive Market Analysis
The global biopharmaceuticals market is marked by the presence of established and emerging market players such as AbbVie Inc., Amgen Inc., AstraZeneca, Eli Lilly and Co., Johnson & Johnson, Merck & Co., Novartis, Novo Nordisk, Pfizer Inc., and Roche Holding AG; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Overview
|
Report Scope |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 – 2024 |
|
Forecast Period |
2025 – 2030 |
|
Growth Rate |
12% |
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
Product, Type, Therapy Area, Distribution Channel |
|
Regional Scope |
|
|
Key Companies Mapped |
AbbVie Inc., Amgen Inc., AstraZeneca, Eli Lilly and Co., Johnson & Johnson, Merck & Co., Novartis, Novo Nordisk, Pfizer Inc., Roche Holding AG among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global biopharmaceuticals market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, type, therapy area, and distribution channel.
- Market Size & Forecast (2023-2030), By Product, USD Million
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Gene Therapies and Cell Therapies
- Others
- Market Size & Forecast (2023-2030), By Type, USD Million
- Innovative
- Biosimilars
- Market Size & Forecast (2023-2030), By Therapy Area, USD Million
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Rare/Orphan Diseases
- Others
- Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the biopharmaceuticals market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the biopharmaceuticals market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Biopharmaceuticals Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of chronic diseases
- Advancements in biotechnology
- Growing geriatric population
- Expansion of biosimilars
- Rising R&D investments
- Restraints
- High development and manufacturing costs
- Complex regulatory processes
- Patent cliffs and market competition
- High production costs
- Challenges in drug stability and storage
- Opportunities
- Expansion in emerging markets
- Innovations in drug delivery systems
- Personalized medicine
- Expanding applications in rare diseases
- Key Market Trends
- Emergence of gene and cell therapies
- Advancements in mRNA technology
- Emphasis on bioprocessing innovations
- Combination therapies
- Unmet Market Needs
- Industry Speaks
- Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Vaccines
- Gene Therapies and Cell Therapies
- Others
- Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Type, USD Million
- Introduction
- Innovative
- Biosimilars
- Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Therapy Area, USD Million
- Introduction
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Rare/Orphan Diseases
- Others
- Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
- Introduction
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Biopharmaceuticals Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Biopharmaceuticals Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- US
- Europe Biopharmaceuticals Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- UK
- Asia Pacific (APAC) Biopharmaceuticals Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- China
- Latin America (LATAM) Biopharmaceuticals Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Middle East & Africa (MEA) Biopharmaceuticals Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Therapy Area (USD Million)
- Market Size & Forecast, By Distribution Channel (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2023-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
-
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca
- Eli Lilly and Co.
- Johnson & Johnson
- Merck & Co.
- Novartis
- Novo Nordisk
- Pfizer Inc.
- Roche Holding AG
- Other Prominent Players
Note *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Healthcare Providers, Researchers, Doctors, Physicians, Specialists, Oncologist, Pharmacists and and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
